Exogenous Acrolein intensifies sensory hypersensitivity after spinal cord injury in rat

Hulsebosch, 2009, Mechanisms of chronic central neuropathic pain after spinal cord injury, Brain Res. Rev., 60, 202, 10.1016/j.brainresrev.2008.12.010 Christensen, 1997, Chronic central pain after spinal cord injury, J. Neurotrauma, 14, 517, 10.1089/neu.1997.14.517 Hagen, 2015, Management of Neuropathic Pain Associated with spinal cord injury, Pain Ther, 4, 51, 10.1007/s40122-015-0033-y Coull, 2003, Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain, Nature, 424, 938, 10.1038/nature01868 Jin, 2003, p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain, J. Neurosci., 23, 4017, 10.1523/JNEUROSCI.23-10-04017.2003 Zhuang, 2005, ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model, Pain, 114, 149, 10.1016/j.pain.2004.12.022 Hamann, 2008, Critical role of acrolein in secondary injury following ex vivo spinal cord trauma, J. Neurochem., 107, 712, 10.1111/j.1471-4159.2008.05622.x Hamann, 2009, Acrolein scavenging: a potential novel mechanism of attenuating oxidative stress following spinal cord injury, J. Neurochem., 111, 1348, 10.1111/j.1471-4159.2009.06395.x Shi, 2011, Acrolein-mediated injury in nervous system trauma and diseases, Mol. Nutr. Food Res., 55, 1320, 10.1002/mnfr.201100217 Scholz, 2007, The neuropathic pain triad: neurons, immune cells and glia, Nat. Neurosci., 10, 1361, 10.1038/nn1992 Gwak, 2011, GABA and central neuropathic pain following spinal cord injury, Neuropharmacology, 60, 799, 10.1016/j.neuropharm.2010.12.030 Coull, 2005, BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain, Nature, 438, 1017, 10.1038/nature04223 B.C. Hains, J.P. Klein, C.Y. Saab, M.J. Craner, J.A. Black, S.G. Waxman, Upregulation of sodium channel Nav1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury, J Neurosci 23(26) (2003) 8881–92. Park, 2015, Acrolein contributes to TRPA1 up-regulation in peripheral and central sensory hypersensitivity following spinal cord injury, J. Neurochem., 135, 987, 10.1111/jnc.13352 Chen, 2016, Mitigation of sensory and motor deficits by acrolein scavenger phenelzine in a rat model of spinal cord contusive injury, J. Neurochem., 138, 328, 10.1111/jnc.13639 Park, 2014, Neuroprotective role of hydralazine in rat spinal cord injury-attenuation of acrolein-mediated damage, J. Neurochem., 129, 339, 10.1111/jnc.12628 Yu, 2013, Alleviation of chronic pain following rat spinal cord compression injury with multimodal actions of huperzine a, Proc. Natl. Acad. Sci. U. S. A., 110, E746, 10.1073/pnas.1300083110 Siddall, 2009, Management of neuropathic pain following spinal cord injury: now and in the future, Spinal Cord, 47, 352, 10.1038/sc.2008.136 Hama, 2009, Antinociceptive effects of the marine snail peptides conantokin-G and conotoxin MVIIA alone and in combination in rat models of pain, Neuropharmacology, 56, 556, 10.1016/j.neuropharm.2008.10.008 Kim, 2012, TRPV1 in GABAergic interneurons mediates neuropathic mechanical allodynia and disinhibition of the nociceptive circuitry in the spinal cord, Neuron, 74, 640, 10.1016/j.neuron.2012.02.039 Due, 2014, Acrolein involvement in sensory and behavioral hypersensitivity following spinal cord injury in the rat, J. Neurochem., 128, 776, 10.1111/jnc.12500 Siddall, 2006, Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial, Neurology, 67, 1792, 10.1212/01.wnl.0000244422.45278.ff Vranken, 2008, Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen, Pain, 136, 150, 10.1016/j.pain.2007.06.033 Levendoglu, 2004, Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury, Spine (Phila Pa 1976), 29, 743, 10.1097/01.BRS.0000112068.16108.3A Tai, 2002, Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial, J Spinal Cord Med, 25, 100, 10.1080/10790268.2002.11753609 Rintala, 2007, Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury, Arch. Phys. Med. Rehabil., 88, 1547, 10.1016/j.apmr.2007.07.038 Cardenas, 2013, A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury, Neurology, 80, 533, 10.1212/WNL.0b013e318281546b Cardenas, 2002, Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial, Pain, 96, 365, 10.1016/S0304-3959(01)00483-3 Chouinard, 1985, A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder, J Clin Psychiatry, 46, 32 Yaksh, 1976, Analgesia mediated by a direct spinal action of narcotics, Science, 192, 1357, 10.1126/science.1273597 Siddall, 2000, The efficacy of intrathecal morphine and clonidine in the treatment of pain after spinal cord injury, Anesth. Analg., 91, 1493, 10.1097/00000539-200012000-00037 Norrbrink, 2009, Transcutaneous electrical nerve stimulation for treatment of spinal cord injury neuropathic pain, J. Rehabil. Res. Dev., 46, 85, 10.1682/JRRD.2008.04.0051 Celik, 2013, The effect of low-frequency TENS in the treatment of neuropathic pain in patients with spinal cord injury, Spinal Cord, 51, 334, 10.1038/sc.2012.159 P.J. Siddall, M.J. Cousins, Persistent pain as a disease entity: implications for clinical management, Anesthesia and analgesia 99(2) (2004) 510–20, table of contents. Yoshida, 2009, Acrolein toxicity: comparison with reactive oxygen species, Biochem. Biophys. Res. Commun., 378, 313, 10.1016/j.bbrc.2008.11.054 Uchida, 1999, Current status of acrolein as a lipid peroxidation product, Trends in Cardiovascular Medicine, 9, 109, 10.1016/S1050-1738(99)00016-X Calingasan, 1999, Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease, J. Neurochem., 72, 751, 10.1046/j.1471-4159.1999.0720751.x Shi, 2006, The role of acrolein in spinal cord injury, Applied Neurology, 2, 22 Shi, 2015, Molecular mechanisms of acrolein-mediated myelin destruction in CNS trauma and disease, Free Radic. Res., 49, 888, 10.3109/10715762.2015.1021696 Bautista, 2006, TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents, Cell, 124, 1269, 10.1016/j.cell.2006.02.023 Bautista, 2013, TRPA1: a gatekeeper for inflammation, Annu. Rev. Physiol., 75, 181, 10.1146/annurev-physiol-030212-183811 Ushio, 2013, Transient receptor potential channel A1 involved in calcitonin gene-related peptide release in neurons, Neural Regen. Res., 8, 3013 Borchers, 2008, Nonredundant functions of alphabeta and gammadelta T cells in acrolein-induced pulmonary pathology, Toxicol. Sci., 105, 188, 10.1093/toxsci/kfn106 Esterbauer, 1991, Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes, Free Radic. Biol. Med., 11, 81, 10.1016/0891-5849(91)90192-6 F. Facchinetti, F. Amadei, P. Geppetti, F. Tarantini, C. Di Serio, A. Dragotto, P.M. Gigli, S. Catinella, M. Civelli, R. Patacchini, Alpha,beta-unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages, Am. J. Respir. Cell Mol. Biol. 37(5) (2007) 617–23. Sato, 1999, Smoke extract stimulates lung fibroblasts to release neutrophil and monocyte chemotactic activities, Am. J. Phys., 277, L1149 Stevens, 2008, Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease, Mol. Nutr. Food Res., 52, 7, 10.1002/mnfr.200700412 Park, 2014, Acrolein as a novel therapeutic target for motor and sensory deficits in spinal cord injury, Neural Regen. Res., 9, 677, 10.4103/1673-5374.131564 Luo, 2005, Accumulation of acrolein-protein adducts after traumatic spinal cord injury, Neurochem. Res., 30, 291, 10.1007/s11064-005-2602-7 Richards, 2005, Effects of smoking on neuropathic pain in two people with spinal cord injury, J Spinal Cord Med, 28, 330, 10.1080/10790268.2005.11753829 Carmella, 2007, Quantitation of acrolein-derived (3-hydroxypropyl)mercapturic acid in human urine by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: effects of cigarette smoking, Chem. Res. Toxicol., 20, 986, 10.1021/tx700075y Jia, 2007, Acrolein, a toxicant in cigarette smoke, causes oxidative damage and mitochondrial dysfunction in RPE cells: protection by (R)-alpha-lipoic acid, Invest. Ophthalmol. Vis. Sci., 48, 339, 10.1167/iovs.06-0248 T. Schettgen, A. Musiol, T. Kraus, Simultaneous determination of mercapturic acids derived from ethylene oxide (HEMA), propylene oxide (2-HPMA), acrolein (3-HPMA), acrylamide (AAMA) and N,N-dimethylformamide (AMCC) in human urine using liquid chromatography/tandem mass spectrometry, Rapid Commun. Mass Spectrom. 22(17) (2008) 2629–38. Tully, 2014, Acute systemic accumulation of acrolein in mice by inhalation at a concentration similar to that in cigarette smoke, Neurosci. Bull., 30, 1017, 10.1007/s12264-014-1480-x Chaplan, 1994, Quantitative assessment of tactile allodynia in the rat paw, J. Neurosci. Methods, 53, 55, 10.1016/0165-0270(94)90144-9 Zheng, 2013, Determination of urine 3-HPMA, a stable Acrolein metabolite in a rat model of spinal cord injury, J. Neurotrauma, 30, 1334, 10.1089/neu.2013.2888 P.X. Chen, S.C. Moldoveanu, Mainstream Smoke Chemical Analyses for 2R4F Kentucky Reference Cigarette, Contrib. to Tob. Res 20 (2003). Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method, Methods, 25, 402, 10.1006/meth.2001.1262 Botterell, 1954, Pain in paraplegia; clinical management and surgical treatment, Proc R Soc Med, 47, 281 Dorman, 2008, Respiratory tract responses in male rats following subchronic acrolein inhalation, Inhal. Toxicol., 20, 205, 10.1080/08958370701864151 Brunnemann, 1990, Analysis of 1,3-butadiene and other selected gas-phase components in cigarette mainstream and sidestream smoke by gas chromatography-mass selective detection, Carcinogenesis, 11, 1863, 10.1093/carcin/11.10.1863 Cole, 1960, Clinical and theoretical observations on phenelzine (nardil), an antidepressant agent, Am. J. Psychiatry, 117, 361, 10.1176/ajp.117.4.361 Yu, 1994, Pharmacological and clinical implications of MAO-B inhibitors, Gen. Pharmacol., 25, 1527, 10.1016/0306-3623(94)90352-2 Merrill, 2012, Transcriptional and translational plasticity in rodent urinary bladder TRP channels with urinary bladder inflammation, bladder dysfunction, or postnatal maturation, J. Mol. Neurosci., 48, 744, 10.1007/s12031-012-9867-5 Schwartz, 2013, TRPV1 and TRPA1 antagonists prevent the transition of acute to chronic inflammation and pain in chronic pancreatitis, J. Neurosci., 33, 5603, 10.1523/JNEUROSCI.1806-12.2013 Boucher, 2000, Cyclophosphamide-induced cystitis in freely-moving conscious rats: behavioral approach to a new model of visceral pain, J. Urol., 164, 203, 10.1016/S0022-5347(05)67495-2 Hilgard, 1986, Cause and prevention of mafosfamide-induced venous pain, Investig. New Drugs, 4, 373, 10.1007/BF00173510 Kunkler, 2011, TRPA1 receptors mediate environmental irritant-induced meningeal vasodilatation, Pain, 152, 38, 10.1016/j.pain.2010.08.021 O'Connor, 2008, Pain associated with multiple sclerosis: systematic review and proposed classification, Pain, 137, 96, 10.1016/j.pain.2007.08.024 Osterberg, 2005, Central pain in multiple sclerosis--prevalence and clinical characteristics, Eur. J. Pain, 9, 531, 10.1016/j.ejpain.2004.11.005 Svendsen, 2005, Sensory function and quality of life in patients with multiple sclerosis and pain, Pain, 114, 473, 10.1016/j.pain.2005.01.015 T.Z. Fischer, S.G. Waxman, Neuropathic pain in diabetes--evidence for a central mechanism, Nat Rev Neurol 6(8) 462–6. Feroe, 2016, Acrolein metabolites, diabetes and insulin resistance, Environ. Res., 148, 1, 10.1016/j.envres.2016.03.015